Hybrid immunoglobulins
US6406697B1 · kind B1 · utility
90Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1997 |
| Grant date | Jun 18, 2002 |
| Priority date | — |
| Expiry date | Aug 5, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.